dc.creatorHemelaar, Joris
dc.creatorGouwsb, Eleanor
dc.creatorGhysb, Peter D.
dc.creatorOsmanov, Saladin
dc.creatorWHO-UNAIDS Network for HIV Isolation and Characterisation
dc.creatorSalomon, Horacio Eduardo
dc.date.accessioned2017-02-20T21:00:12Z
dc.date.accessioned2018-11-06T14:30:00Z
dc.date.available2017-02-20T21:00:12Z
dc.date.available2018-11-06T14:30:00Z
dc.date.created2017-02-20T21:00:12Z
dc.date.issued2011-03
dc.identifierHemelaar, Joris; Gouwsb, Eleanor; Ghysb, Peter D.; Osmanov, Saladin; WHO-UNAIDS Network for HIV Isolation and Characterisation; et al.; Global trends in molecular epidemiology of HIV-1 during 2000-2007; Lippincott Williams; Aids; 25; 5; 3-2011; 679-689
dc.identifier0269-9370
dc.identifierhttp://hdl.handle.net/11336/13189
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1887089
dc.description.abstractObjective To estimate the global and regional distribution of HIV-1 subtypes and recombinants between 2000 and 2007. Design Country-specific HIV-1 molecular epidemiology data were combined with estimates of the number of HIV-infected people in each country. Method Cross-sectional HIV-1 subtyping data were collected from 65913 samples in 109 countries between 2000 and 2007. The distribution of HIV-1 subtypes in individual countries was weighted according to the number of HIV-infected people in each country to generate estimates of regional and global HIV-1 subtype distribution for the periods 2000–2003 and 2004–2007. Results Analysis of the global distribution of HIV-1 subtypes and recombinants in the two time periods indicated a broadly stable distribution of HIV-1 subtypes worldwide with a notable increase in the proportion of circulating recombinant forms (CRFs), a decrease in unique recombinant forms (URFs), and an overall increase in recombinants. In 2004–2007, subtype C accounted for nearly half (48%) of all global infections, followed by subtypes A (12%) and B (11%), CRF02_AG (8%), CRF01_AE (5%), subtype G (5%) and D(2%). Subtypes F, H, J and K together cause fewer than 1% of infections worldwide. Other CRFs and URFs are each responsible for 4% of global infections, bringing the combined total of worldwide CRFs to 16% and all recombinants (CRFs plus URFs) to 20%. Conclusions The global and regional distributions of individual subtypes and recombinants are broadly stable, although CRFs may play an increasing role in the HIV pandemic. The global diversity of HIV-1 poses a formidable challenge to HIV vaccine development.
dc.languageeng
dc.publisherLippincott Williams
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://journals.lww.com/aidsonline/pages/articleviewer.aspx?year=2011&issue=03130&article=00018&type=abstract
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1097/QAD.0b013e328342ff93
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755761/
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcirculating recombinant form
dc.subjectHIV
dc.subjectmolecular epidemiology
dc.subjectrecombinant
dc.subjectsubtype
dc.subjectvaccine
dc.titleGlobal trends in molecular epidemiology of HIV-1 during 2000-2007
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución